Ticker LaunchCanada to US · Uplisting from OTC · INM
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM), a British Columbia-based company, listed on Nasdaq on Nov 5, 2020, registering its securities on Form 8-A12B. It is also listed in Canada on TSX: IN.
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company developing prescription cannabinoid-based products for diseases with high unmet medical needs. It also develops IntegraSyn, a biosynthesis-based manufacturing approach for producing pharmaceutical-grade cannabinoids.
- Type
- Uplisting from OTC
- US exchange
- Nasdaq
- Ticker
- INM
- Listed
- Nov 5, 2020
- Province
- British Columbia
- Registration form
- 8-A12B
- Security
- Common shares
- Canadian listing
- TSX: IN
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (8-A12B) Nov 5, 2020
- Offering document
- All filings on EDGAR CIK 1728328
Other Canadian companies listing in the US
- Orla Mining Ltd.NYSE American · Dec 4, 2020
- Docebo Inc.Nasdaq · Dec 1, 2020
- CI Financial Corp.NYSE · Nov 4, 2020
- Absolute Software CorpNasdaq · Oct 26, 2020
- GoldMining Inc.NYSE American · Sep 25, 2020
- ImmunoPrecise Antibodies Ltd.Nasdaq · Sep 16, 2020